Pharmaceutical Contract Sales Outsourcing (CSO) Market (Therapeutic Area: Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Jul 2022| TMR3200A| Transparency

Report Highlights

Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market – Scope of Report

TMR’s report on the pharmaceutical contract sales outsourcing (CSO) market in Europe studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the pharmaceutical contract sales outsourcing (CSO) market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of pharmaceutical contract sales outsourcing (CSO) market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the pharmaceutical contract sales outsourcing (CSO) market in Europe.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the pharmaceutical contract sales outsourcing (CSO) market in Europe.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the pharmaceutical contract sales outsourcing (CSO) market in Europe. These serve as valuable tools for existing market players as well as for entities interested in participating in the pharmaceutical contract sales outsourcing (CSO) market in Europe.

The report delves into the competitive landscape of the pharmaceutical contract sales outsourcing (CSO) market. Key players operating in the pharmaceutical contract sales outsourcing (CSO) market in Europe have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the pharmaceutical contract sales outsourcing (CSO) market profiled in this report.

Research Methodology

The research methodology is a combination of exhaustive primary and secondary research to analyze the pharmaceutical contract sales outsourcing (CSO) market.

Secondary Research

Secondary research included a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we referred to include, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical papers, product brochures
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

  • Industry Sources:
  • Veterinary Council of Europe
  • Europen Federation of Animal Health
  • Animal Welfare Board of Europe
  • Company Information
  • Statista
  • Hoover’s
  • Factiva
  • Bloomberg
  • Mergers & Acquisitions
  • Thomson Mergers & Acquisitions
  • MergerStat
  • Profound

Primary Research

During the course of the research, we conducted in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents the bulk of research efforts, supplemented by extensive secondary research.

We conducted primary interviews with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who took part in the process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts
  • Key opinion leaders specializing in the market with respect to different industry verticals

Primary participants included, but are not limited to:

  • Bayer AG
  • Elanco Products Company
  • Merck & Co., Inc.
  • Ceva Sante Animale
  • Virbac SA

 

 

Frequently Asked Questions (FAQs)

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter

Market Estimation: Market size estimations involved an in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we used modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Population, inflation rates, and others

Industry Indicators: Production data, R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived by taking into account drivers, restraints/challenges, opportunities prevailing in the market, and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise consumption data are the other pivotal factors considered to derive market forecasts.

  • Table 1 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Service, 2017–2031
  • Table 2 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Personal Promotion, 2017–2031
  • Table 3 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017–2031
  • Table 4 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Non-personal Promotion, 2017–2031
  • Table 5 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031
  • Table 6 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 7 : Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Service, 2017–2031
  • Table 8 : Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Personal Promotion, 2017–2031
  • Table 9 : Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017–2031
  • Table 10 : Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Non-personal Promotion, 2017–2031
  • Table 11 : Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031
  • Table 12 : U.K. Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Service, 2017–2031
  • Table 13 : U.K. Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Personal Promotion, 2017–2031
  • Table 14 : U.K. Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017–2031
  • Table 15 : U.K. Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Non-personal Promotion, 2017–2031
  • Table 16 : U.K. Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031
  • Table 17 : France Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Service, 2017–2031
  • Table 18 : France Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Personal Promotion, 2017–2031
  • Table 19 : France Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017–2031
  • Table 20 : France Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Non-personal Promotion, 2017–2031
  • Table 21 : France Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031
  • Table 22 : Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Service, 2017–2031
  • Table 23 : Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Personal Promotion, 2017–2031
  • Table 24 : Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017–2031
  • Table 25 : Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Non-personal Promotion, 2017–2031
  • Table 26 : Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031
  • Table 27 : Spain Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Service, 2017–2031
  • Table 28 : Spain Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Personal Promotion, 2017–2031
  • Table 29 : Spain Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017–2031
  • Table 30 : Spain Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Non-personal Promotion, 2017–2031
  • Table 31 : Spain Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031
  • Table 32 : Rest of Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Service, 2017–2031
  • Table 33 : Rest of Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Personal Promotion, 2017–2031
  • Table 34 : Rest of Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017–2031
  • Table 35 : Rest of Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Non-personal Promotion, 2017–2031
  • Table 36 : Rest of Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031
  • Figure 1 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 2 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share, by Service, 2021
  • Figure 3 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share, by Therapeutic Area, 2021
  • Figure 4 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share, by Country/Sub-region, 2021
  • Figure 5 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Service, 2021 and 2031
  • Figure 6 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Service, 2022–2031
  • Figure 7 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), by Personal Promotion, 2017–2031
  • Figure 8 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), Non-personal Promotion, 2017–2031
  • Figure 9 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), by Others, 2017–2031
  • Figure 10 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Therapeutic Area, 2021 and 2031
  • Figure 11 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Therapeutic Area 2022–2031
  • Figure 12 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), by Cardiovascular Disorders, 2017–2031
  • Figure 13 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), Oncology, 2017–2031
  • Figure 14 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), by Metabolic Disorders, 2017–2031
  • Figure 15 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), Neurology, 2017–2031
  • Figure 16 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), by Orthopedic Diseases, 2017–2031
  • Figure 17 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), Infectious Diseases, 2017–2031
  • Figure 18 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 19 : Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 20 : Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 21 : Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Service, 2021 and 2031
  • Figure 22 : Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Service, 2022–2031
  • Figure 23 : Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Therapeutic Area, 2021 and 2031
  • Figure 24 : Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Therapeutic Area, 2022–2031
  • Figure 25 : U.K. Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 26 : U.K. Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Service, 2021 and 2031
  • Figure 27 : U.K. Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Service, 2022–2031
  • Figure 28 : U.K. Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Therapeutic Area, 2021 and 2031
  • Figure 29 : U.K. Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Therapeutic Area, 2022–2031
  • Figure 30 : France Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 31 : France Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Service, 2021 and 2031
  • Figure 32 : France Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Service, 2022–2031
  • Figure 33 : France Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Therapeutic Area, 2021 and 2031
  • Figure 34 : France Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Therapeutic Area, 2022–2031
  • Figure 35 : Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 36 : Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Service, 2021 and 2031
  • Figure 37 : Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Service, 2022–2031
  • Figure 38 : Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Therapeutic Area, 2021 and 2031
  • Figure 39 : Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Therapeutic Area, 2022–2031
  • Figure 40 : Spain Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 41 : Spain Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Service, 2021 and 2031
  • Figure 42 : Spain Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Service, 2022–2031
  • Figure 43 : Spain Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Therapeutic Area, 2021 and 2031
  • Figure 44 : Spain Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Therapeutic Area, 2022–2031
  • Figure 45 : Rest of Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 46 : Rest of Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Service, 2021 and 2031
  • Figure 47 : Rest of Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Service, 2022–2031
  • Figure 48 : Rest of Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Therapeutic Area, 2021 and 2031
  • Figure 49 : Rest of Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Therapeutic Area, 2022–2031

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Transparency
Price: $5795

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS